Guidance has already been published in the report from the Committee on
Safety of Medicines Expert Working Group on Patient Information entitled
“Always read the leaflet – getting the best information with every medicine”
which is available from our website. This document reiterates some key
messages from this publication and puts forward additional advice in the area
of patient information.
Quality information depends on two factors – design and layout of the
information and the content. Both of these are equally important and need to
be given careful consideration before submitting leaflets for user testing. The
test will identify problems with the information but will not correct these. The
quality needs to be built in prior to testing in order to achieve success.